Literature DB >> 12397430

Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene.

Felix K Jacobi1, Sten Andréasson, Hana Langrova, Alfons Meindl, Eberhart Zrenner, Eckart Apfelstedt-Sylla, Carsten M Pusch.   

Abstract

PURPOSE: To describe the clinical phenotype of the complete type of X-linked congenital stationary night blindness (CSNB1) with different types of mutations in the NYX gene.
METHODS: The clinical and genetic data from 18 male patients with eight different mutations from two ophthalmological institutes were reviewed. The variability in refractive error, reduced visual acuity and full-field electroretinogram (ERG) recordings was examined.
RESULTS: Parameters were quantitatively analyzed based on the classification of mutations according to their predicted effect on protein structure and function. CSNB1 patients with mutations changing structurally conserved residues ( n=12) tended to have a lower degree of myopia than patients with mutations of non-conserved residues ( n=6). Visual acuity loss and the 30 Hz flicker ERG recordings were similar in the two groups. Values for the b/a amplitude ratio tended to be clustered in patients carrying the same mutation. Refractive error and the b/a amplitude ratio were highly correlated between the two eyes of an individual.
CONCLUSIONS: These data suggest correlations between phenotypic expression in CSNB1 and individual genotypes as well as class types of mutations based on the extent of structural amino acid conservation. A high inter-eye correlation suggests that other genetic or environmental factors, rather than chance, play a part in determining the phenotypic diversity in CSNB1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397430     DOI: 10.1007/s00417-002-0562-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Congenital stationary night blindness associated with mutations in GRM6 encoding glutamate receptor MGluR6.

Authors:  E O'Connor; L E Allen; K Bradshaw; J Boylan; A T Moore; D Trump
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Nature and nurture: the complex genetics of myopia and refractive error.

Authors:  R Wojciechowski
Journal:  Clin Genet       Date:  2010-12-13       Impact factor: 4.438

3.  CSNB1 in Chinese families associated with novel mutations in NYX.

Authors:  Xueshan Xiao; Xiaoyun Jia; Xiangming Guo; Shiqiang Li; Zhikuan Yang; Qingjiong Zhang
Journal:  J Hum Genet       Date:  2006-05-03       Impact factor: 3.172

4.  Isolation and characterization of the leucine-rich proteoglycan nyctalopin gene (cNyx) from chick.

Authors:  N Torben Bech-Hansen; Josh Cockfield; Dan Liu; C Cairine Logan
Journal:  Mamm Genome       Date:  2005-10-29       Impact factor: 2.957

5.  Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete X-linked congenital stationary night blindness.

Authors:  Ronald G Gregg; Maarten Kamermans; Jan Klooster; Peter D Lukasiewicz; Neal S Peachey; Kirstan A Vessey; Maureen A McCall
Journal:  J Neurophysiol       Date:  2007-09-19       Impact factor: 2.714

6.  Zebrafish Cacna1fa is required for cone photoreceptor function and synaptic ribbon formation.

Authors:  Sujuan Jia; Akira Muto; Wilda Orisme; Hannah E Henson; Chaithanyarani Parupalli; Bensheng Ju; Herwig Baier; Michael R Taylor
Journal:  Hum Mol Genet       Date:  2014-01-12       Impact factor: 5.121

7.  Congenital blindness and visual impairment cause infection or non infection.

Authors:  Mirjana A Janicijevic-Petrovic; Tatjana S Sarenac-Vulovic; Katarina M Janicijevic; Dragan I Vujic; Dejan D Vulovic
Journal:  Mater Sociomed       Date:  2013

8.  Mutations in NYX of individuals with high myopia, but without night blindness.

Authors:  Qingjiong Zhang; Xueshan Xiao; Shiqiang Li; Xiaoyun Jia; Zhikuan Yang; Shizhou Huang; Rafael C Caruso; Tianqin Guan; Yuri Sergeev; Xiangming Guo; J Fielding Hejtmancik
Journal:  Mol Vis       Date:  2007-03-01       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.